Palo Alto Investors LP Long-Term Concentrated

Location: Palo Alto, CA

CIK: 0001306923 · Show all filings

Period: Q3 2017 (← Previous) (Next →)

Filing Date: Nov 14, 2017

Total Value: $2.374B (100.0% shares, 0.0% debt)

Holdings (40)

ABIOMED INC 13.7%
Value $326M Shares 1,935,300 Est. Cost $32.04 Unrealized
CLOVIS ONCOLOGY INC 11.6%
Value $274M Shares 3,329,581 Est. Cost $54.10 Unrealized
BMRN BIOMARIN PHARMACEUTICAL INC 9.6%
Value $227M Shares 2,438,519 Est. Cost $79.50 Unrealized +11.2%
UTHR UNITED THERAPEUTICS CORP DEL 8.7%
Value $207M Shares 1,762,650 Est. Cost $88.34 Unrealized +44.6%
INSM INSMED INC 8.1%
Value $193M Shares 6,171,816 Est. Cost $15.01 Unrealized +26.9%
ALEXION PHARMACEUTICALS INC 6.4%
Value $152M Shares 1,080,342 Est. Cost $121.12 Unrealized
EPIZYME INC 5.1%
Value $122M Shares 6,398,296 Est. Cost $15.31 Unrealized
FOLD AMICUS THERAPEUTICS INC 4.7%
Value $112M Shares 7,420,288 Est. Cost $6.23 Unrealized +112.3%
VNDA VANDA PHARMACEUTICALS INC 3.1%
Value $74.39M Shares 4,155,670 Est. Cost $8.70 Unrealized +92.3%
PRTA PROTHENA CORP PLC 3.0%
Value $70.97M Shares 1,095,655 Est. Cost $32.98 Unrealized +85.7%
WRIGHT MED GROUP N V 2.9%
Value $69.24M Shares 2,676,393 Est. Cost $23.44 Unrealized
AMAG PHARMACEUTICALS INC 2.7%
Value $63.49M Shares 3,441,233 Est. Cost $29.62 Unrealized
ACAD ACADIA PHARMACEUTICALS INC 2.6%
Value $61.82M Shares 1,641,030 Est. Cost $29.82 Unrealized +9.1%
SAGE THERAPEUTICS INC 2.1%
Value $49.05M Shares 787,251 Est. Cost $42.59 Unrealized
STAA STAAR SURGICAL CO 1.8%
Value $43.66M Shares 3,507,052 Est. Cost $8.00 Unrealized +39.3%
CELGENE CORP 1.8%
Value $43.05M Shares 295,240 Est. Cost $97.51 Unrealized
IMMUNOMEDICS INC 1.8%
Value $42.09M Shares 3,010,466 Est. Cost $8.83 Unrealized
ALGN ALIGN TECHNOLOGY INC 1.8%
Value $41.56M Shares 223,107 Est. Cost $94.04 Unrealized +82.0%
KARYOPHARM THERAPEUTICS INC 1.6%
Value $38.41M Shares 3,498,585 Est. Cost $19.70 Unrealized
MOMENTA PHARMACEUTICALS INC 1.4%
Value $33.21M Shares 1,794,998 Est. Cost $14.13 Unrealized
AIMMUNE THERAPEUTICS INC 1.4%
Value $32.07M Shares 1,293,764 Est. Cost $22.25 Unrealized
EXAS EXACT SCIENCES CORP 0.9%
Value $20.41M Shares 433,076 Est. Cost $13.61 Unrealized +195.7%
SHIRE PLC 0.8%
Value $19.94M Shares 130,200 Est. Cost $219.26 Unrealized
GILD GILEAD SCIENCES INC 0.6%
Value $14.25M Shares 175,900 Est. Cost $62.02 Unrealized -9.8%
BIOVERATIV INC 0.5%
Value $12.06M Shares 211,300 Est. Cost $57.07 Unrealized
RIGEL PHARMACEUTICALS INC 0.4%
Value $9.792M Shares 3,855,024 Est. Cost $3.39 Unrealized
ACELRX PHARMACEUTICALS INC 0.2%
Value $4.75M Shares 1,032,715 Est. Cost $5.54 Unrealized
ALIMERA SCIENCES INC 0.2%
Value $4.069M Shares 3,013,793 Est. Cost $4.88 Unrealized
DICERNA PHARMACEUTICALS INC 0.1%
Value $2.88M Shares 500,913 Est. Cost $5.39 Unrealized
SUNESIS PHARMACEUTICALS INC 0.1%
Value $2.255M Shares 1,162,473 Est. Cost $4.37 Unrealized
CYTK CYTOKINETICS INC 0.1%
Value $1.793M Shares 123,686 Est. Cost $6.71 Unrealized +103.5%
IDERA PHARMACEUTICALS INC 0.1%
Value $1.374M Shares 616,355 Est. Cost $3.70 Unrealized
CEMPRA INC 0.0%
Value $1.106M Shares 340,320 Est. Cost $22.71 Unrealized
ZOGENIX INC 0.0%
Value $1.034M Shares 29,500 Est. Cost $13.36 Unrealized
TREVENA INC 0.0%
Value $870K Shares 341,300 Est. Cost $2.30 Unrealized
ALDER BIOPHARMACEUTICALS INC 0.0%
Value $789K Shares 64,400 Est. Cost $12.25 Unrealized
HISTOGENICS CORP 0.0%
Value $600K Shares 302,922 Est. Cost $11.00 Unrealized
SOPHIRIS BIO INC 0.0%
Value $530K Shares 247,000 Est. Cost $2.60 Unrealized
ALCOBRA LTD 0.0%
Value $276K Shares 272,788 Est. Cost $5.98 Unrealized
SOLENO THERAPEUTICS INC 0.0%
Value $220K Shares 84,748 Est. Cost $0.50 Unrealized